<DOC>
	<DOCNO>NCT01839877</DOCNO>
	<brief_summary>Treatment patient colorectal cancer liver metastases currently base systemic chemotherapy . Triple therapy 5FU , oxaliplatin irinotecan intravenously effective term response secondary resectability , however particularly toxic . Hepatic intra-arterial chemotherapy ( HIA ) subject several study . It show good efficacy oxaliplatin FUDR . However , procedure difficult set reserve experienced center . The objective protocol use triple therapy base 5FU oxaliplatin associated irinotecan administer hepatic intra-arterial route , load onto microbeads ( DEBIRI ) . Furthermore , procedure chemo-embolization DEBIRI limit 2 session , therefore could easily generalize .</brief_summary>
	<brief_title>Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX Patients With Colorectal Cancer With Unresectable Liver Metastases : Phase II Multicenter Study</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Histologically proven colorectal adenocarcinoma , Liver metastases radiologically histologically prove At least one measurable liver lesion RECIST v1.1 Age ≥ 18 year WHO Index &lt; = 2 Life expectancy ≥ 3 month No extrahepatic disease except lung nodule number &lt; = 3 size &lt; 10 mm Healthy liver &lt; 60 % Primary tumor resect still place No prior chemotherapy metastasis treatment ( except perioperative chemotherapy , last cycle administer least 12 month ago ) Adjuvant chemotherapy resection primary authorize last cycle administer least 12 month ago Normal hepatic function : total bilirubin ≤ 1.5 N ; AST ≤ 5N ; ALT ≤ 5N PAL ≤ 5N TP ≥ 60 % Adequate hematologic function : ANC ≥ 1500/mm3 , platelet ≥ 100 000/mm3 , Hb ≥ 9g/dl Good renal function : creatinine clearance ≥ 60 mL / min No cardiac dysfunction : cardiovascular event last 6 month NYHA ≥ 2 Patient eligible curative treatment ( resection / radiofrequency ablation ) multidisciplinary decision ( include opinion liver surgeon ) Pregnant lactate woman patient sex childbearing age use adequate contraception History cancer , except skin cancer ( melanoma ) , carcinoma situ cervix uterus treat curative . Other cancer treat curative intent permit provide relapse last 5 year Peripheral neuropathy Inflammatory Bowel Diseases Intestinal obstruction Chronic liver disease ( viral , alcoholic metabolic ) Immune Deficiency Syndromes ( history transplantation , infection HIV ) Known contraindication 5FU , oxaliplatin , folinic acid , irinotecan contrast product Patients known contraindication hepatic embolization procedure : Presence biliarydigestive anastomosis biliary stent Cruoric tumor thrombosis portal vein Patient psychological , social , family geographical reason could follow regularly Legal disability ( person deprive liberty guardianship ) Patient affiliate social security scheme Participation another concurrent study investigate effect treatment 4 week end concurrent study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Metastatic colorectal Cancer</keyword>
</DOC>